Update on FDA’s ongoing evaluation of reports of suicidal thoughts or actions in patients taking a certain type of medicines approved for type 2 diabetes and obesity.
Preliminary evaluation does not suggest a causal link.
Preliminary evaluation does not suggest a causal link.
